Research Library

In 2026, the USMCA will undergo an open-ended review that could result in anything from minor changes to significant renegotiations. Nonresident fellow Simon Lester discusses this unprecedented process and argues that the U.S. and Mexico must follow Canada’s lead in starting preparations.

Recent federal research security initiatives have put the U.S. at risk of losing its lead in science and technology, write senior fellow Neal F. Lane, Steven Pei, and Jeremy Wu. They lay out a path toward clear, fair policy that safeguards America’s security and competitiveness while fostering a welcoming research environment for foreign talent.

The safety and efficacy of many stem cell treatments remain unproven by the FDA, yet state laws promote access and use of these unchecked and potentially harmful treatments. Fellow Kirstin R.W. Matthews summarizes her recent publication in a new commentary — outlining public health consequences of these state laws and calling for scientific societies’ advocacy in state policymaking.

“Nearly one billion travelers pass through U.S. airports each year,” writes Alicia L. Johnson, civic science postdoctoral associate. In a new commentary, she outlines how the CDC’s genomic surveillance program, which monitors airport wastewater for traces of infectious disease, must balance public health and privacy concerns.

Federal marijuana legalization is on the horizon — and it’s time for the DEA to get behind the policy changes and move on to fighting more dangerous drugs, writes nonresident fellow Gary Hale.

Considering the dangers of advanced AI and AI-enhanced social media, there is an urgent need to design neuroscience-based policies to support citizens in building a system of digital self-defense. Enter the “Neuroshield.”

Mexican President Andrés Manuel López Obrador's deference to drug cartels in Mexico reveals that he is not interested in meaningful cooperation on bilateral drug law enforcement, and his administration should be regarded as hostile to U.S. interests, writes nonresident fellow Gary Hale.

The rapid adoption of telemedicine is one of the few positive developments of the COVID-19 pandemic, writes fellow Katharine Neill Harris. She explains why the DEA’s recent proposal to change the rules for prescribing drugs via telemedicine would harm patients and increase demand for and exposure to unregulated and more dangerous drugs.

In 2022, the nation faced fundamental questions about how we govern our economy and society — particularly how we formulate public policy. Here, we share 10 highlights of our work that illustrate our impact from the previous year.